Antje E. Rinckleb

2.0k total citations
11 papers, 195 citations indexed

About

Antje E. Rinckleb is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Antje E. Rinckleb has authored 11 papers receiving a total of 195 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 5 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Antje E. Rinckleb's work include Prostate Cancer Treatment and Research (5 papers), DNA Repair Mechanisms (3 papers) and BRCA gene mutations in cancer (3 papers). Antje E. Rinckleb is often cited by papers focused on Prostate Cancer Treatment and Research (5 papers), DNA Repair Mechanisms (3 papers) and BRCA gene mutations in cancer (3 papers). Antje E. Rinckleb collaborates with scholars based in Germany, United States and Netherlands. Antje E. Rinckleb's co-authors include Manuel Luedeke, Walther Vogel, Christiane Maier, Josef Hoegel, Harald Surowy, Janet L. Stanford, Matthias D. Hofer, Rainer Kuefer, Mark A. Rubin and Dominic Varga and has published in prestigious journals such as PLoS ONE, American Journal of Epidemiology and International Journal of Cancer.

In The Last Decade

Antje E. Rinckleb

11 papers receiving 192 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Antje E. Rinckleb Germany 7 97 86 63 47 37 11 195
Polina Gervas Russia 10 143 1.5× 67 0.8× 64 1.0× 57 1.2× 88 2.4× 31 267
Nadiya Sosonkina United States 8 115 1.2× 40 0.5× 25 0.4× 70 1.5× 26 0.7× 14 212
Wenyong Zhang China 9 118 1.2× 33 0.4× 56 0.9× 35 0.7× 28 0.8× 20 214
Stacey E. P. Joosten Netherlands 7 91 0.9× 32 0.4× 54 0.9× 58 1.2× 65 1.8× 9 184
Khoon Leong Ng Malaysia 6 156 1.6× 41 0.5× 75 1.2× 19 0.4× 55 1.5× 10 287
Wubin Ding China 7 248 2.6× 84 1.0× 74 1.2× 26 0.6× 41 1.1× 10 314
Andrea Y. Angstadt United States 6 162 1.7× 107 1.2× 134 2.1× 72 1.5× 34 0.9× 7 296
Celine Chen United States 4 96 1.0× 60 0.7× 24 0.4× 17 0.4× 39 1.1× 5 187
Fujun Qiu China 7 111 1.1× 51 0.6× 119 1.9× 23 0.5× 33 0.9× 21 192
Minoru Ichikawa Japan 9 118 1.2× 37 0.4× 42 0.7× 11 0.2× 25 0.7× 24 215

Countries citing papers authored by Antje E. Rinckleb

Since Specialization
Citations

This map shows the geographic impact of Antje E. Rinckleb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antje E. Rinckleb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antje E. Rinckleb more than expected).

Fields of papers citing papers by Antje E. Rinckleb

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antje E. Rinckleb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antje E. Rinckleb. The network helps show where Antje E. Rinckleb may publish in the future.

Co-authorship network of co-authors of Antje E. Rinckleb

This figure shows the co-authorship network connecting the top 25 collaborators of Antje E. Rinckleb. A scholar is included among the top collaborators of Antje E. Rinckleb based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antje E. Rinckleb. Antje E. Rinckleb is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
2.
Surowy, Harald, Dominic Varga, Barbara Burwinkel, et al.. (2017). A low‐frequency haplotype spanning SLX4/FANCP constitutes a new risk locus for early‐onset breast cancer (<60 years) and is associated with reduced DNA repair capacity. International Journal of Cancer. 142(4). 757–768. 4 indexed citations
3.
Geybels, Milan S., Joshi J. Alumkal, Manuel Luedeke, et al.. (2015). Epigenomic profiling of prostate cancer identifies differentially methylated genes in TMPRSS2:ERG fusion-positive versus fusion-negative tumors. Clinical Epigenetics. 7(1). 128–128. 30 indexed citations
4.
Wright, Jonathan L., Sarah K. Holt, Daniel W. Lin, et al.. (2015). Aspirin and NSAID use in association with molecular subtypes of prostate cancer defined by TMPRSS2:ERG fusion status. Prostate Cancer and Prostatic Diseases. 19(1). 53–56. 14 indexed citations
5.
Luedeke, Manuel, Antje E. Rinckleb, Suzanne Kolb, et al.. (2015). Obesity and Prostate Cancer Risk According to Tumor TMPRSS2:ERG Gene Fusion Status. American Journal of Epidemiology. 181(9). 706–713. 17 indexed citations
6.
Maier, Christiane, Kathleen Herkommer, Manuel Luedeke, et al.. (2014). Subgroups of familial and aggressive prostate cancer with considerable frequencies ofBRCA2mutations. The Prostate. 74(14). 1444–1451. 20 indexed citations
7.
Reiter, Rudolf, Sibylle Brosch, Antje E. Rinckleb, et al.. (2014). Do Orofacial Clefts Represent Different Genetic Entities?. The Cleft Palate-Craniofacial Journal. 52(1). 115–120. 6 indexed citations
8.
Luedeke, Manuel, Natalia Bogdanova, Antje E. Rinckleb, et al.. (2012). Prostate Cancer Risk Is not Altered by TP53AIP1 Germline Mutations in a German Case-Control Series. PLoS ONE. 7(3). e34128–e34128. 6 indexed citations
9.
Rinckleb, Antje E., Harald Surowy, Manuel Luedeke, et al.. (2012). The prostate cancer risk locus at 10q11 is associated with DNA repair capacity. DNA repair. 11(8). 693–701. 4 indexed citations
10.
Surowy, Harald, Antje E. Rinckleb, Manuel Luedeke, et al.. (2010). Heritability of baseline and induced micronucleus frequencies. Mutagenesis. 26(1). 111–117. 34 indexed citations
11.
Luedeke, Manuel, Matthias D. Hofer, Harald Surowy, et al.. (2009). Predisposition for TMPRSS2-ERG Fusion in Prostate Cancer by Variants in DNA Repair Genes. Cancer Epidemiology Biomarkers & Prevention. 18(11). 3030–3035. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026